ABSTRACT Aim: Vitamin D stimulates production of the endogenous antimicrobial peptides cathelicidin and b-defensin-2, which are expressed in the urinary tract. We investigated vitamin D status and levels of cathelicidin and b-defensin-2 and their association with urinary tract infection (UTI).
INTRODUCTION
Urinary tract infections (UTIs) belong to the most common bacterial infections and carry a high risk of recurrence. Antibiotics are being the main treatment for UTIs and in many cases, low-dose antibiotics are used as prophylaxis of recurrent infections. This strategy has been poorly efficient and leads to rise of bacterial resistance to antibiotics (1), a serious threat to global public health. Alternative treatments are therefore urgently needed.
In most cases, UTIs are caused by bacteria, ascending from the perineum. In the urinary tract, bacteria encounter a strong mucosal immunity. Endogenous antimicrobial peptides (AMPs) belong to this first line of defence (2) . AMPs are expressed in immune cells and at epithelial surfaces of all multicellular organisms (3) . Two main families of AMPs are found in mammals, the cathelicidins and the defensins. There is only one cathelicidin but several defensins in humans. Cathelicidin knockout mice have confirmed the importance of cathelicidin in protection of the urinary tract (4). Of several described defensins, b-defensin-1 and -2 are expressed in the urinary tract (5) . b-defensin-1 is expressed constitutively and b-defensin-2 is induced during UTI. Both cathelicidin and defensins interact with microbial cytoplasmic membrane which leads to membrane lysis. In addition to antimicrobial activity, AMPs inhibit biofilm formation and modulate various immune processes (6) . Importantly, vitamin D is a known inducer of both human cathelicidin and b-defensin-2 (7, 8) . 
Key notes
Vitamin D deficiency and insufficiency are common in infants and small children despite prescribed supplementation with vitamin D. Vitamin D levels are lower in girls and decrease with age in infancy. Low vitamin D levels but not low levels of antimicrobial peptides are associated with first-time urinary tract infection in girls.
There is clear in vitro evidence that vitamin D influences various processes of innate and adaptive immunity (9) . The association between vitamin D levels and several infectious diseases has been appreciated for a long time. Moreover, prophylaxis and even treatment of both tuberculosis and respiratory tract infections with vitamin D have been successful (10) . In other infections, however, large clinical studies brought conflicting results (11) .
This study explores an association between first-time and recurrent UTI and levels of vitamin D, cathelicidin and b-defensin-2 in young children to better understand the pathogenesis of UTI and eventually to develop new prophylactic and treatment options for this disease.
MATERIALS AND METHODS

Ethics statement
The local ethics committee in Stockholm, Sweden, approved the study and informed consent was obtained from the parents.
Subjects and data collection
The study is a cross-sectional study and includes 120 children less than three years of age examined at the Paediatric nephrology unit at Karolinska University Hospital, Huddinge, Stockholm, between March 2012 and October 2016, due to UTI or congenital hydronephrosis. According to the standards described below, the children were examined with renal scintigraphy using technetium99m dimercaptosuccinic acid (DMSA) or technetium-99m mercaptoacetyltriglycine (MAG3). Vitamin D and AMPs were analysed at the time of scintigraphy. All studied children were during the first two years of life prescribed with vitamin D 400 IU daily, according to the guidelines of the Nordic Nutrition Recommendation (12) . All children under two years of age in Sweden receive vitamin D prophylaxis free of charge and the parents get vitamin D drops during regular visits at child care centres, once a month during the first year of life and twice yearly during the second year of life.
Age, sex, time of the year, body temperature, results of laboratory analyses, including C-reactive protein and microbiology results, type of treatment and prophylaxis were analysed from the children's electronic medical records.
Children with UTI were also followed prospectively. Information about UTI relapses during the period of one year after the index infection was received from the children's medical records. Information about possible nondocumented relapses (e. g. due to seeking medical care abroad or in hospitals in Sweden with different medical data system) was completed via individual telephone interviews with the parents of the children one year after the initial infection. There were no exclusion criteria except for age.
Definition of UTI
The diagnostic criteria of acute UTI in the study were clinical symptoms suggestive of a UTI such as unexplained fever, vomiting, malaise, lethargy and the presence of >10 5 bacteria/mL urine collected by mid-stream clean catch. Any bacterial growth in urine collected by suprapubic aspirations was considered diagnostic for UTI.
Imaging after UTI Ultrasound of the kidneys and urinary tract and renal scintigraphy (DMSA) were performed in all UTI cases. Ultrasound was performed within one week and scintigraphy approximately one to two months after the UTI. Renal static scintigraphy was performed and analysed as described before (13) . Shortly, each kidney was divided into three segments. Normal uptake in each segment was given the value 0, and decreased uptake was graded 1-3. From the size and degree of a defect in DMSA uptake, a DMSA score was calculated.
If the ultrasound or scintigraphy was abnormal, a micturating urethrocystography (MUCG) was performed. According to the results of the MUCG, the children were divided into three categories: no vesicoureteral reflux (VUR), nondilated VUR (grade I and II) and dilated VUR (grade III-V) (14) .
Congenital hydronephrosis
The diagnostic criterion for congenital hydronephrosis was dilatation of the foetal renal collecting system with anteroposterior diameter ≥5 mm in the second trimester of pregnancy, in accordance with the guidelines in our unit (15) . The post-natal follow-up protocol included renal ultrasound and, for the children with persistent significant hydronephrosis, MUCG and renal scintigraphy (MAG3). Sample collection and analysis Blood samples were taken at the time of renal scintigraphy, that is one to two months after the infection for the children with UTI. The blood for the analysis of 25(OH)D 3 was collected to gel serum tubes (BD Vacutainer, Plymouth, UK) and analysed directly after sampling. The blood for the analysis of levels of AMPs was collected into EDTA plasma tubes (BD) and centrifuged within 30 minutes at 15009g for 15 minutes. Plasma was then transferred into new tubes and stored at À80°C prior to analysis. Serum 25(OH)D 3 levels were analysed by direct competitive electro-chemiluminescence immunoassay at the laboratory of Karolinska University Hospital, Huddinge. Plasma cathelicidin and human b-defensin-2 were measured using ELISA kits (Hycult biotech and Alpha Diagnostic, respectively), according to the manufacturer's instructions. 
Definition of vitamin D deficiency and insufficiency
Statistical analyses
RESULTS
Our study included 120 children with the median age of 11.4 months (range 4.5-33.5), 61 (51%) of the children were boys and 59 girls. Of these 120 children, 76 (63%) had had UTI and 44 had not. First, we analysed all children together, irrespectively of the history of UTI. Low vitamin D levels are associated with UTI in girls Our study group consisted of 76 children with UTI and 44 children without a history of UTI. In further analyses, we focused on the UTI group. Children without a history of UTI are referred to as controls.
The most common clinical symptom in UTI patients was fever, that is body temperature 38.5°C or higher, present in 50 patients (66%). Other symptoms included abdominal pain, vomiting, low appetite and being unwell. The most common aetiological agent was Escherichia coli, isolated in 68 patients (89%), of which four isolates were extended spectrum b-lactamase (ESBL) positive. Two patients (2.6%) were diagnosed with Klebsiella oxytoca infection, and two patients had significant growth of Proteus mirabilis in urine culture. There was one patient (1.3%) with Klebsiella pneumoniae, one with Group B Streptococcus and one with Enterococcus faecalis infection. One patient had a urine culture with mixed growth of E. coli and K. oxytoca. In one of the patients, no aetiological agent could be identified, probably due to already started antibiotic treatment. This patient was included in the study due to positive DMSA scintigraphy. The children received a 10-day antibiotic treatment, which was followed by an antibiotic prophylaxis until MUCG, both according to the antibiotic sensitivity pattern of the isolated agent. The most common antibiotics used were cephalosporins in 69 patients (90.7%), three patients (3.9%) were treated with trimethoprim, two patients (2.6%) received nitrofurantoin. Ciprofloxacin and phenoxymethylpenicillin were used in one patient each (1.3%).
The peak of UTI incidence was found in four-month-old infants (15% of cases) with decreased frequency thereafter. UTI was more common in girls (64%) compared with boys and 74% cases of UTI occurred during colder and darker half of the year in Sweden, October-March. DMSA uptake defects were found in 18% (14/77) children. The presence or the degree of the defect expressed as a DMSA score did not correlate with vitamin D, cathelicidin or b-defensin-2 levels (p > 0.05, Spearman's rank correlation test). Dilated VUR (grade 3-4) was found by MUCG in seven of 76 children (9%).
We further analysed the two studied groups (UTI and Controls) in terms of vitamin D and AMPs. In the UTI group, we found significantly lower serum levels of vitamin D (p < 0.0001, t-test), plasma levels of cathelicidin (p < 0.0001, Mann-Whitney test) and plasma levels of b-defensin-2 (p < 0.0001, Mann-Whitney test). UTI group and Controls differed in sex distribution due to higher proportion of girls in the UTI group (49/76 girls in the UTI group vs. 10/44 girls in the control group, p < 0.0001, Fisher's exact test), as well as in age (median 15 months, range 5-34 months in the UTI group vs. median four months, range 0-30 months in the control group, p < 0.01, Mann-Whitney U test). When analysed separately for girls and boys, we found that girls with UTI had lower levels of vitamin D as compared with girls without a history of UTI (p < 0.01, ANOVA with Bonferroni adjustment) (Fig. 3 ) but no significant difference in plasma concentrations of cathelicidin and b-defensin-2 were found (p > 0.05, ANOVA). The difference was independent of age (multiple regression). In boys, no association between vitamin D, AMPs and UTI was found (p > 0.05, ANOVA).
Vitamin D and AMPs cathelicidin and b-defensin-2 are not associated with recurrence of UTI We followed our group of UTI patients for one year after the infection. We analysed if serum levels of vitamin D or plasma levels of cathelicidin or b-defensin-2 were associated with recurrent UTIs. Of 76 children with UTI, 21 (28%) had a recurrence within one year after the index infection. There was no association between levels of vitamin D, cathelicidin or b-defensin-2 and recurrence of UTI (p > 0.05, Mann-Whitney U test). The recurrence rate in the group with dilated VUR was 4/7 (57%) vs. 17/69 (25%) in the group without dilated reflux (p = 0.09, Fisher's exact test).
DISCUSSION
In this study, we describe vitamin D status and plasma levels of AMPs cathelicidin and b-defensin-2 in children under three years of age as well as their association with UTI and certain demographic characteristics. We found that 21% of the children in our study had vitamin D deficiency or insufficiency despite prescribed daily vitamin D supplementation during the first two years of life. Similarly, another Swedish study found inadequate vitamin D status in a large group of preschool children living in northern Sweden (17) . Inadequate vitamin D levels in children are reported not only in Sweden, an area with relatively low sun exposure but also in many other countries worldwide, both with high and low sun exposure, as well as in countries both with and without routine supplementation with vitamin D (18) . The low levels of vitamin D may advocate a better vitamin D prophylaxis. Another possibility is that the methods how we measure vitamin D status or the definition of normal range for vitamin D levels may need revision.
Vitamin D and its metabolites are bound to serum proteins, mainly the vitamin D-binding protein (DBP), such that less than 1% of the total concentration of vitamin D and its metabolites are free in the circulation. Vitamin D enters the cells mostly as a free hormone. Levels and affinity of DBP are influenced by race, obesity, sex, female hormones, liver disease and multimorbidity, reviewed in (19) . Some authors try to calculate levels of free and bioavailable vitamin D based on levels of albumin, DBP levels and DBP characteristics. Others measure free 25 (OH)D 3 directly. Free 25(OH)D 3 highly correlated with total 25(OH)D 3 in most subjects and was inversely related to levels of parathormone (19) . We have therefore decided for measuring of total 25(OH)D 3 in our study. In the future, however, addressing different forms and metabolites of vitamin D and innate immunity may be of interest.
Vitamin D is traditionally known for its effect on calcium and phosphate homeostasis. Over the last years, more and more data have shown that vitamin D influences almost all organ systems and all processes in the human body. In vitro, vitamin D displays multiple effects on both innate and adaptive immunity. Therefore, many animal experiments and clinical studies sought to find an association or causality between vitamin D and infectious diseases. Vitamin D stimulates production of AMPs and thus enhances immunity against tuberculosis and respiratory infections (10) . When it comes to other infections, data are scarce or less convincing (11) . We and others have previously shown that vitamin D stimulates production of cathelicidin and b-defensin-2 (7), AMPs protecting the urinary tract from bacterial infections. As non-infected urine contains extremely low levels of AMPs, we have previously measured cathelicidin in human bladder biopsies and found increased expression of cathelicidin in the bladder mucosa after treatment with vitamin D (7). In the current study, we found a correlation between levels of 25(OH)D 3 and cathelicidin in plasma, further confirming previous results.
Interestingly, vitamin D, cathelicidin and b-defensin-2 negatively correlated with children's age with younger children having the highest levels. In children over three years of age, the levels seem to increase again (20) . If we draw parallels with other epithelial surfaces (21) , the innate immunity in form of AMPs, supported with adequate levels of vitamin D, may be of a crucial importance early in life, where the adaptive immune system is still building up. Accordingly, maternal levels of vitamin D increase during pregnancy, possibly to be ready to protect the early postpartum life (22) .
In our study, girls had significantly lower levels of vitamin D compared with boys. A similar sex difference has been shown also in other studies (23) , most of them conducted on older children, but the reasons for the difference are still unclear. Another recent study found significant differences in testosterone levels in male and female placentas, as well as different levels of vitamin D and cathelicidin (24) . Sex hormones may therefore play a role even in foetal and early post-natal life. Vitamin D metabolism might also be directly or indirectly influenced by sex chromosomes which are believed to be the case for other factors of the immune system (25) .
Vitamin D deficiency in our study was associated with UTI in girls. Similarly, vitamin D deficiency was associated with both recurrent UTIs in premenopausal women (26) and first-time UTIs in infants (27) . High dose of vitamin D supplementation in postmenopausal women decreased severity of urine incontinence (28) . In an interventional study with vitamin D treatment and primary focus on respiratory infection, a reduced incidence of UTI in men has been observed (29) . Interestingly, although vitamin D levels correlated with plasma levels of cathelicidin, UTI was associated only with vitamin D deficiency and not with low levels of cathelicidin. This finding may imply that alternative mechanisms behind the protective effect of vitamin D may be involved. One such mechanism could be a vitamin D effect on the cytoskeleton of bladder epithelial cells as shown recently in cell culture and in an animal model of UTI (30) .
In conclusion, our data suggest that guidelines for normal vitamin D levels and/or supplementation may need revision. Inadequate vitamin D levels may be a risk factor for the first UTI in girls. Further studies are needed to determine preventive effect of vitamin D on UTI.
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